Epilepsy and COVID-19: Connection and Considerations
A brief communication provides information about the associations between, and the considerations for, COVID-19 and epilepsy.
General Infectious Disease
Relapse of Paracoccidioidomycosis in the Central Nervous System
A patient with a history of pulmonary paracoccidioidomycosis presented with relapsed disease in the central nervous system four years after initial treatment.
Neurologic Features Tied to ARDS in Severe COVID-19 Described
Acute respiratory distress syndrome (ARDS) due to COVID-19 is associated with neurologic features, including encephalopathy, agitation, and confusion
Many Health Care Workers Face Risk for Poor Outcomes With COVID-19
The researchers found that 3.66 million of 13.79 million health care workers with patient contact (26.6 percent) are at risk for poor COVID-19 outcomes due to age or chronic conditions.
FDA Approves Quadrivalent Meningococcal Vaccine MenQuadfi
The FDA has approved MenQuadfiTM Meningococcal (Groups A, C, Y, W; Sanofi Pasteur) Conjugate Vaccine for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y in patients aged ≥2 years.
Neurocognitive Conditions Among People Living With HIV
Neurologic conditions associated with HIV remain major contributors to morbidity and mortality, and are increasingly recognized in the aging population of individuals living with HIV.
The Most Cases of COVID-19 Are in the United States: 5 Updates on the Pandemic
The effects of the COVID-19 pandemic have caused more significant change than previously expected as the United States now has the most cases worldwide.
Surgical, Cotton Masks Not Effective for Filtering SARS-CoV-2
For patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), neither surgical nor cotton masks effectively filter SARS-CoV-2 during coughs.
AHA/ASA Issues Guidance for Optimal Stroke Care During COVID-19 Pandemic
AHA/ASA Stroke Council leadership published temporary emergency guidance for stroke management in the midst of COVID-19.
Discontinuation of Dolutegravir Due to Neurologic Side Effects Linked to Pre-Existing Mental Illness
Dolutegravir (DTG) discontinuation due to neuropsychologic side effects (NPS) may be associated with pre-existing psychiatric conditions of depression and anxiety.
Next post in Neurobehavioral Disorders
